StemSight
Developer of an off-the-shelf cell therapy platform designed to treat blindness. The company's platform treats cells based on induced pluripotent stem cells (iPSCs) and biomaterials, and it aims to en...
Valuation
$0
Share Price
N/A
Total Raised
$3.5M
Last Round
N/A